[Myelofibrosis following a hyposecreting myeloma treated by vincristine, melphalan].
D000368:Aged; D005260:Female; D006801:Humans; D008558:Melphalan / Q000009:adverse effects* / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000378:metabolism; D055728:Primary Myelofibrosis / Q000139:chemically induced*; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D014750:Vincristine; D008558:Melphalan
Myélofibrose succédant à un myélome hypoexcrétant traité par vincristine, melphalan.